KR102093708B1 - A cosmetic composition using Fraxini cortex extract - Google Patents
A cosmetic composition using Fraxini cortex extract Download PDFInfo
- Publication number
- KR102093708B1 KR102093708B1 KR1020190062728A KR20190062728A KR102093708B1 KR 102093708 B1 KR102093708 B1 KR 102093708B1 KR 1020190062728 A KR1020190062728 A KR 1020190062728A KR 20190062728 A KR20190062728 A KR 20190062728A KR 102093708 B1 KR102093708 B1 KR 102093708B1
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- hair
- chimney
- cosmetic composition
- delete delete
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 73
- 239000002537 cosmetic Substances 0.000 title claims abstract description 36
- 239000000203 mixture Substances 0.000 title claims abstract description 31
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 16
- 239000008213 purified water Substances 0.000 claims description 15
- 238000000855 fermentation Methods 0.000 claims description 10
- 230000004151 fermentation Effects 0.000 claims description 10
- 235000011187 glycerol Nutrition 0.000 claims description 8
- 239000007787 solid Substances 0.000 claims description 5
- 239000007864 aqueous solution Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000000052 vinegar Substances 0.000 claims description 3
- 235000021419 vinegar Nutrition 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 41
- 208000002874 Acne Vulgaris Diseases 0.000 abstract description 26
- 206010000496 acne Diseases 0.000 abstract description 26
- 210000002374 sebum Anatomy 0.000 abstract description 19
- 241000282577 Pan troglodytes Species 0.000 abstract description 14
- 230000003779 hair growth Effects 0.000 abstract description 12
- 230000002401 inhibitory effect Effects 0.000 abstract description 11
- 230000028327 secretion Effects 0.000 abstract description 11
- -1 more specifically Substances 0.000 abstract description 10
- 230000002265 prevention Effects 0.000 abstract description 10
- 230000003658 preventing hair loss Effects 0.000 abstract description 8
- 230000003700 hair damage Effects 0.000 abstract description 7
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 239000002904 solvent Substances 0.000 abstract description 5
- 239000012141 concentrate Substances 0.000 abstract 1
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 18
- 235000019441 ethanol Nutrition 0.000 description 15
- 210000004209 hair Anatomy 0.000 description 14
- 239000006210 lotion Substances 0.000 description 14
- 238000012360 testing method Methods 0.000 description 13
- 239000006071 cream Substances 0.000 description 12
- 210000003491 skin Anatomy 0.000 description 11
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 229960003604 testosterone Drugs 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 230000007794 irritation Effects 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 229960003473 androstanolone Drugs 0.000 description 6
- 239000003205 fragrance Substances 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 239000002453 shampoo Substances 0.000 description 6
- 201000004384 Alopecia Diseases 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 230000003664 tensile strength of the hair Effects 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 210000002950 fibroblast Anatomy 0.000 description 4
- 230000003676 hair loss Effects 0.000 description 4
- 208000024963 hair loss Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 230000001629 suppression Effects 0.000 description 4
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 3
- 230000003656 anti-hair-loss Effects 0.000 description 3
- 239000001768 carboxy methyl cellulose Substances 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 235000012469 Cleome gynandra Nutrition 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920001007 Nylon 4 Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 230000003255 anti-acne Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000000686 essence Substances 0.000 description 2
- 235000019439 ethyl acetate Nutrition 0.000 description 2
- 125000004494 ethyl ester group Chemical group 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 230000009036 growth inhibition Effects 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 150000004702 methyl esters Chemical class 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- 239000008194 pharmaceutical composition Substances 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 210000001732 sebaceous gland Anatomy 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- QRTADFOPPOKFDH-UHFFFAOYSA-N 20,21-dihydroxyhenicosanoic acid Chemical compound OCC(O)CCCCCCCCCCCCCCCCCCC(O)=O QRTADFOPPOKFDH-UHFFFAOYSA-N 0.000 description 1
- PLXMOAALOJOTIY-FPTXNFDTSA-N Aesculin Natural products OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](O)[C@H]1Oc2cc3C=CC(=O)Oc3cc2O PLXMOAALOJOTIY-FPTXNFDTSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000132092 Aster Species 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- WNBCMONIPIJTSB-BGNCJLHMSA-N Cichoriin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1)c1c(O)cc2c(OC(=O)C=C2)c1 WNBCMONIPIJTSB-BGNCJLHMSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 241000186427 Cutibacterium acnes Species 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- GMRNMZUSKYJXGJ-UHFFFAOYSA-N Fraxetin Natural products C1=CC(=O)C(=O)C2=C1C=C(OC)C(O)=C2O GMRNMZUSKYJXGJ-UHFFFAOYSA-N 0.000 description 1
- CRSFLLTWRCYNNX-UHFFFAOYSA-N Fraxin Natural products OC=1C(OC)=CC=2C=CC(=O)OC=2C=1OC1OC(CO)C(O)C(O)C1O CRSFLLTWRCYNNX-UHFFFAOYSA-N 0.000 description 1
- 241001536358 Fraxinus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 240000004670 Glycyrrhiza echinata Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000005859 Orthosiphon aristatus Species 0.000 description 1
- 229920002535 Polyethylene Glycol 1500 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 1
- 239000003655 absorption accelerator Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- QNHQEUFMIKRNTB-UHFFFAOYSA-N aesculetin Natural products C1CC(=O)OC2=C1C=C(O)C(O)=C2 QNHQEUFMIKRNTB-UHFFFAOYSA-N 0.000 description 1
- GUAFOGOEJLSQBT-UHFFFAOYSA-N aesculetin dimethyl ether Natural products C1=CC(=O)OC2=C1C=C(OC)C(OC)=C2 GUAFOGOEJLSQBT-UHFFFAOYSA-N 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000058 anti acne agent Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940124340 antiacne agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- WACQKHWOTAEEFS-UHFFFAOYSA-N cyclohexane;ethyl acetate Chemical compound CCOC(C)=O.C1CCCCC1 WACQKHWOTAEEFS-UHFFFAOYSA-N 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 239000003405 delayed action preparation Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- ILEDWLMCKZNDJK-UHFFFAOYSA-N esculetin Chemical compound C1=CC(=O)OC2=C1C=C(O)C(O)=C2 ILEDWLMCKZNDJK-UHFFFAOYSA-N 0.000 description 1
- XHCADAYNFIFUHF-TVKJYDDYSA-N esculin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC2=C1OC(=O)C=C2 XHCADAYNFIFUHF-TVKJYDDYSA-N 0.000 description 1
- 229940093496 esculin Drugs 0.000 description 1
- AWRMZKLXZLNBBK-UHFFFAOYSA-N esculin Natural products OC1OC(COc2cc3C=CC(=O)Oc3cc2O)C(O)C(O)C1O AWRMZKLXZLNBBK-UHFFFAOYSA-N 0.000 description 1
- 235000010944 ethyl methyl cellulose Nutrition 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- HAVWRBANWNTOJX-UHFFFAOYSA-N fraxetin Chemical compound C1=CC(=O)OC2=C1C=C(OC)C(O)=C2O HAVWRBANWNTOJX-UHFFFAOYSA-N 0.000 description 1
- CRSFLLTWRCYNNX-QBNNUVSCSA-N fraxin Chemical compound OC=1C(OC)=CC=2C=CC(=O)OC=2C=1O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O CRSFLLTWRCYNNX-QBNNUVSCSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 210000000260 male genitalia Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229920003087 methylethyl cellulose Polymers 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 210000003007 myelin sheath Anatomy 0.000 description 1
- BOUCRWJEKAGKKG-UHFFFAOYSA-N n-[3-(diethylaminomethyl)-4-hydroxyphenyl]acetamide Chemical compound CCN(CC)CC1=CC(NC(C)=O)=CC=C1O BOUCRWJEKAGKKG-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 229940093430 polyethylene glycol 1500 Drugs 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920001289 polyvinyl ether Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920001592 potato starch Polymers 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000002027 skeletal muscle Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 230000021595 spermatogenesis Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 235000010487 tragacanth Nutrition 0.000 description 1
- 239000000196 tragacanth Substances 0.000 description 1
- 229940116362 tragacanth Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Dermatology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 침피 추출물을 주요 활성성분으로 함유하는 화장료 조성물에 관한 것으로서, 좀 더 구체적으로는 물푸레나무 수피를 용매를 이용하여 추출하고, 농축 및 동결건조하여 제조된 침피 추출물을 0.001 ~ 1.0중량%를 함유하며 과다 피지 분비 억제효과, 여드름 방지효과, 모발 손상 방지효과, 탈모방지 및 육모 효과가 우수한 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a chimpanzee extract as a main active ingredient, more specifically, extract the ash tree bark using a solvent, concentrate and freeze-dried the chimpanzee extract prepared by 0.001 ~ 1.0% by weight It relates to a cosmetic composition containing excellent sebum secretion inhibitory effect, acne prevention effect, hair damage prevention effect, hair loss prevention and hair growth effect.
Description
본 발명은 물푸레나무과 물푸레나무(Fraxinus rhynchophylla)의 수피인 침피(Fraxini Cortex) 추출물을 주요 활성성분으로 함유하는 화장료 조성물에 관한 것으로서, 좀 더 구체적으로는 침피 추출물을 유효성분으로 0.001 ~ 1.0중량%로 함유하는 것을 특징으로 하며 피부의 과잉으로 분비되는 피지를 억제하여, 여드름 방지 효과, 모발손상 방지효과, 탈모 방지 및 육모 효과가 우수한 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a chimney (Fraxini Cortex) extract, which is a bark of the ash family (Frixinus rhynchophylla ) as a main active ingredient, and more specifically, the chimney extract as an active ingredient in an amount of 0.001 to 1.0% by weight. It relates to a cosmetic composition that is characterized in that it contains, and suppresses sebum secreted by excess of the skin, excellent in preventing acne, preventing hair damage, preventing hair loss, and hair growth.
침피(Fraxini cortex)는 물푸레나무과의 물푸레나무(Fraxinus rhynchopylla)의 수피를 건조한 것이다. 물푸레나무는 낙엽성 교목이며 높이는 15m 정도까지 자라며 지름은 60cm 정도 하는 키가 큰 나무이다. 심목, 청피목(靑皮木)으로도 불려진다. 이름의 유래는 껍질을 우려내면 물이 파란색으로 변하여 물푸레나무라는 이름이 붙여진 것이다. 나뭇잎은 마주나며 4~8개의 잎으로 이루어지고, 잎 꼭지의 연장부의 좌우 양쪽에 두 잎 이상의 작은 잎이 배열하여 새의 깃 모양을 이룬 복엽(複葉)이다. 길이는 15cm 정도 하는 피침모양이다. 표면에는 털이 없지만 뒷면에는 털이 있는 것이 특징이다. 한방에서는 그 나무껍질을 침피(秦皮)라는 약재로 사용하고 있으며 신경통, 안충혈, 부종 등에 약재로 사용하며, 수피에 esculin, mannitol, fraxin, esculetin, fraxetin 등의 성분이 함유되어 있는 것으로 알려져 있다. The Fraxini cortex is a dried bark of the ash tree ( Fraxinus rhynchopylla ). The ash tree is a deciduous tree. It is a tall tree that grows up to 15 m in height and 60 cm in diameter. It is also called Simmok and Cheongpimok. The origin of the name is that the water turns blue when you peel off the bark and is named ash tree. The leaves are opposite to each other, and consist of 4 to 8 leaves. Two or more small leaves are arranged on both sides of the left and right sides of the extension of the leaf tip to form the feathers of a bird. It is lanceolate about 15cm long. It is characterized by having hair on the back, but not on the back. In Chinese medicine, the bark is used as a medicine called chimpi (피), and is used as a medicine for neuralgia, hemoptysis, and edema. It is known that bark contains components such as esculin, mannitol, fraxin, esculetin, and fraxetin.
이러한 물푸레나무의 수피인 침피 추출물은 항염, 피부자극 완화 및 콜라겐 생합성 촉진 효과와 관련된 기술로, "진피 추출물을 주요 활성 성분으로 함유하는 피부외용제조성물"(한국 등록특허공보 제10-0732564호, 특허문헌 1)이 공개되어 있으나, 피지 억제 및 여드름 방지 효과 그리고 탈모 방지 및 육모 효과에 대해서는 보고된 바 없는 실정이다.The bark extract, which is the bark of the ash tree, is a technology related to anti-inflammatory, skin irritation, and collagen biosynthesis promoting effects. "Skin external preparation containing dermis extract as the main active ingredient" (Korean Patent Publication No. 10-0732564, Patent) Literature 1) has been published, but there has been no report on sebum suppression and acne prevention effects and hair loss prevention and hair growth effects.
남성형 탈모증은 남성호르몬 의존적이어서 남성호르몬의 양에 직접적인 관계가 있으며, 이에 따라 최근 남성호르몬 활성억제를 통한 탈모의 예방 및 치료를 위한 많은 연구가 보고되고 있다. 한편, 남성호르몬의 분비상승에 의해 피지선의 기능이 활발해지면 생성된 과잉 피지가 모낭벽의 과각화로 인하여 모낭 내에 정체되면서 생기는 면포가 여드름의 초기단계이다. 남성호르몬에 의한 탈모 및 여드름의 기전을 설명하면, 5-알파-리덕타아제(5-α-Reductase)는 피지선, 모낭, 전립선, 부고환 등의 남성 호르몬 반응성 조직에 존재하는 남성 호르몬들 중 하나로서, 테스토스테론(testosterone)을 디하이드로 테스토스테론(dihydrotestosterone)으로 대사시키는데 관여하는 효소이며, 그 전환에는 NADPH를 필요로 한다. 또한, 테스토스테론은 남성 성충동, 골격근 증가, 남성외부생식기, 음낭성장, 정자형성 등에 관여하고, 디하이드로테스토스테론은 여드름, 피지 증가, 탈모 및 전립선 비대증 등의 해당 조직에 관여한다. 특히, 사춘기 이후에 남성 호르몬의 과량 분비는 여드름과 탈모를 유발하는데, 5-알파-리덕타아제에 의하여 생성되는 남성 호르몬의 활성형태인 디하이드로테스토스테론의 과량 생성을 막기 위해 5-알파-리덕타아제 억제제를 사용하여 과다 피비 분비 억제, 탈모방지 및 여드름 방지제를 개발하려는 연구들이 활발히 진행되고 있다. Since male pattern alopecia is male hormone-dependent, it is directly related to the amount of male hormone, and accordingly, many studies have been reported for the prevention and treatment of hair loss by inhibiting male hormone activity. On the other hand, when the function of the sebaceous gland becomes active due to the increase in the secretion of male hormone, the cotton fabric generated as the excess sebum produced stagnates in the hair follicle due to the hyperkeratization of the follicle wall is the initial stage of acne. When explaining the mechanism of male hair loss and acne, 5-alpha-reductase is one of the male hormones present in testosterone-responsive tissues such as sebaceous glands, hair follicles, prostate, and epididymis. , It is an enzyme involved in metabolizing testosterone to dihydrotestosterone, and NADPH is required for its conversion. In addition, testosterone is involved in male sex drive, skeletal muscle increase, male genital organs, scrotum growth, spermatogenesis, etc., and dihydrotestosterone is involved in relevant tissues such as acne, sebum increase, hair loss and prostate hyperplasia. In particular, after puberty, excessive secretion of testosterone causes acne and hair loss. 5-alpha-reducta is used to prevent overproduction of dihydrotestosterone, an active form of testosterone produced by 5-alpha-reductase. Researches have been actively undertaken to develop inhibitors of hyperphobia, anti-hair loss, and anti-acne agents using azeotropic inhibitors.
이러한 피부의 문제점을 해결하기 위하여, 최근 여러 화학물질 등에 의한 피부 자극을 줄이기 위해 천연물을 사용한 화장품이 많이 개발되고 있다. 천연 재료는 피부에 부작용이 적을 뿐 아니라, 최근 천연 재료를 이용한 화장품에 대한 소비자들의 호응이 높아짐에 따라 화장품 원료로서 개발가치가 한층 늘어나고 있다.In order to solve this problem of skin, many cosmetics using natural products have been developed to reduce skin irritation due to various chemicals. Natural ingredients have fewer side effects on the skin, and recently, as consumers' response to cosmetics using natural ingredients has increased, the development value of cosmetics has increased.
본 발명은 침피 추출물을 함유하는 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition containing a chimpanzee extract.
보다 구체적으로, 본 발명의 목적은 화장료에 적용 가능하고 화장료에 함유 시 과다 피지 분비의 억제 효과, 여드름 방지 효과, 모발손상 방지효과, 탈모 방지효과 및 육모효과를 갖는 천연 추출물이 포함된 화장료 조성물을 제공하려는 것이다.More specifically, the object of the present invention is a cosmetic composition that can be applied to a cosmetic and contains a natural extract having an effect of inhibiting excessive sebum secretion, preventing acne, preventing hair damage, preventing hair loss, and promoting hair growth when contained in a cosmetic. Is to provide.
본 발명의 침피 추출물을 이용한 화장료 조성물은 상기와 같은 과제를 해결하기 위하여, 5 알파-리덕타아제의 활성 억제 효과를 갖는 침피(秦皮)추출물을 유효성분으로 함유하는 것을 특징으로 한다.The cosmetic composition using the chimpanzee extract of the present invention is characterized in that it contains the chimpi extract having an inhibitory effect on the activity of 5 alpha-reductase as an active ingredient in order to solve the above problems.
상기한 구성에 있어서, 상기 침피 추출물은 화장료 조성물 전체에 대하여 0.001 ~ 1.0 중량%로 함유하는 것을 특징으로 한다.In the above configuration, the chimney extract is characterized in that it contains 0.001 to 1.0% by weight relative to the entire cosmetic composition.
또, 상기 침피 추출물은, 정제수, 메탄올, 에탄올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄 또는 헥산 중에서 선택된 1종 이상의 용매를 이용하여 추출한 것을 특징으로 한다.In addition, the chimney extract is characterized in that it is extracted using at least one solvent selected from purified water, methanol, ethanol, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane or hexane.
또한, 상기 침피 추출물은, 물푸레나무 수피를 상온에서 추출하고 냉침 및 여과한 후 50℃ 이하에서 감압농축 및 동결건조하는 것을 특징으로 한다.In addition, the chimney extract is characterized by extracting ash bark at room temperature, cooling and filtering, and then concentrated under reduced pressure and freeze-dried at 50 ° C or lower.
더불어, 상기 화장료 조성물은 과다 피지 분비 억제용인 것을 특징으로 한다.In addition, the cosmetic composition is characterized in that for suppressing excessive sebum secretion.
또는, 상기 화장료 조성물은 여드름 방지용인 것을 특징으로 한다.Or, the cosmetic composition is characterized in that for preventing acne.
또, 상기 화장료 조성물은 모발 손상 방지용인 것을 특징으로 한다.In addition, the cosmetic composition is characterized in that for preventing hair damage.
더하여, 상기 화장료 조성물은 탈모 방지 및 육모용인 것을 특징으로 한다.In addition, the cosmetic composition is characterized in that it is for hair loss prevention and hair growth.
본 발명의 화장료 조성물 제형은 화장수, 젤, 수용성 리퀴드, 크림, 연고, 에센스, 샴푸, 헤어린스, 헤어트리트먼트, 헤어무스, 립스틱, 수중유(O/W)형 또는 유중수(W/O)형의 화장료 조성물 중에서 선택되는 것을 특징으로 한다.The cosmetic composition formulation of the present invention includes lotion, gel, water-soluble liquid, cream, ointment, essence, shampoo, hair rinse, hair treatment, hair mousse, lipstick, oil-in-water (O / W) or water-in-oil (W / O) It is characterized in that it is selected from cosmetic compositions of the type.
또는, 글리세린 및 침피 추출물이 용해된 정제수와, 에탄올 및 묘수초 발효액을 포함하여 구성되되, 상기 정제수 100 중량부를 기준으로 에탄올은 9.4 ~ 9.5 중량부로 구성되고, 상기 침피 추출물은 정제수 100 중량부를 기준으로 0.057 ~ 0.059 중량부로 구성되며, 상기 묘수초 발효액은 정제수 100 중량부를 기준으로 1.18 ~ 1.19 중량부로 구성되고, 상기 침피 추출물은, 세절하여 음건한 물푸레나무의 줄기 껍질을 정제수에 70%(v/v) 에탄올 수용액으로 6시간 환류추출하고 냉각한 후, 여과지로 여과한 다음, 여과된 추출물은 50℃ 이하에서 감압농축 및 동결건조하여 제조되고, 상기 묘수초 발효액은, 묘수초 잎을 수득한 다음, 묘수초, 소금, 식초를 1 : 3 : 1의 비율로 혼합한 다음 1개월동안 발효시키고, 고형물을 분리한 상등액만을 수득하여 제조되는 것을 특징으로 한다.Or, the purified water is dissolved in glycerin and chimpanzee extract, and is composed of ethanol and seedling plant fermentation broth, based on 100 parts by weight of ethanol is composed of 9.4 to 9.5 parts by weight, the chimney extract is based on 100 parts by weight of purified water It is composed of 0.057 ~ 0.059 parts by weight, the myochoweed fermentation broth is composed of 1.18 ~ 1.19 parts by weight based on 100 parts by weight of purified water, and the chimney extract, 70% (v / v / v) ) After reflux extraction with an ethanol aqueous solution for 6 hours, cooled, filtered with filter paper, and the filtered extract is prepared by concentrating under reduced pressure and freeze-drying at 50 ° C. or less, and the seedling water fermentation broth, after obtaining a seedling leaf, It is characterized by being prepared by mixing seedlings, salt, and vinegar at a ratio of 1: 3 and then fermenting for 1 month, and obtaining only the supernatant from which the solids are separated. The.
본 발명에 따른 침피 추출물은 남성호르몬 생성과 밀접한 관련이 있는 5-알파-리덕타아제의 활성 억제하여 과다 피지 분비 억제 효과를 나타내었다.The chimney extract according to the present invention exhibited an inhibitory effect on excessive sebum secretion by inhibiting the activity of 5-alpha-reductase, which is closely related to male hormone production.
또한, 침피 추출물은 모발손상 및 탈모방지 효과와 여드름 방지 효과를 갖는 여드름균 항균활성 효과를 나타내었다.In addition, the chimpanzee extract exhibited antibacterial activity effects for acne bacteria having anti-hair loss and anti-acne effects.
따라서, 이러한 침피 추출물을 함유하는 화장수, 크림, 유액, 팩, 파우더 등의 화장료 조성물은 여드름 방지, 모발손상 방지, 탈모 방지 및 육모 효과 등 우수한 피부 외용제 효과를 가짐을 알 수 있다.Therefore, it can be seen that cosmetic compositions such as lotions, creams, emulsions, packs, powders, etc., containing such a chimney extract have excellent skin external agent effects such as acne prevention, hair damage prevention, hair loss prevention, and hair growth effect.
본 출원의 발명자들은 오랜 연구 끝에 물푸레나무 침피를 선정하고 이로부터 추출물을 제조하여, 과다 피지 분비 억제효과, 여드름 방지효과, 모발손상 방지효과, 탈모방지 및 육모 효과를 측정한 결과, 그 효과가 우수하여 화장료로서의 효능을 기대할 수 있다는 것을 발견하게 되었다.The inventors of the present application, after a long study, selected the ash tree chimney and prepared an extract therefrom, the result of measuring excessive sebum secretion suppression effect, acne prevention effect, hair damage prevention effect, hair loss prevention, and hair growth effect is excellent. Therefore, it was discovered that the efficacy as a cosmetic can be expected.
이에 따른 본 발명은 침피 추출물을 함유하는 화장료 조성물을 제공한다. Accordingly, the present invention provides a cosmetic composition containing a chimney extract.
또한, 본 발명의 상기 침피 추출물은 화장료 조성물 전체에 대해서 동결건조중량 기준 0.001~1.0중량%로 함유하는 것을 특징으로 한다. 상기 추출물의 함량이 0.001중량% 미만인 경우에는 피부개선 효과가 거의 없으며, 1.0중량% 이상인 경우세포독성이 있고, 함유량 증가에 대한 효과 증대 정도가 미미하여 경제적이지 못하다.In addition, the chimney extract of the present invention is characterized in that it contains 0.001 to 1.0% by weight based on the freeze-dried weight with respect to the entire cosmetic composition. When the content of the extract is less than 0.001% by weight, there is almost no skin improvement effect, and when it is 1.0% by weight or more, it has cytotoxicity, and the degree of increase in the effect on the content increase is not economical.
또한, 본 발명은 상기 침피 추출물 추출용매는 정제수, 메탄올, 에탄올, 글리세린, 에틸아세테이트, 부틸렌글리콜, 프로필렌글리콜, 디클로로메탄 및 헥산 중에서 선택된 1종 이상의 용매를 사용하여 추출한 것을 특징으로 한다. In addition, the present invention is characterized in that the extraction solvent of the chimney extract is extracted using at least one solvent selected from purified water, methanol, ethanol, glycerin, ethyl acetate, butylene glycol, propylene glycol, dichloromethane and hexane.
또한, 본 발명은 상기 침피 추출물은 상온에서 추출하고 냉침 및 여과한 후 50℃ 이하에서 감압농축 및 동결건조하는 것을 특징으로 한다.In addition, the present invention is characterized in that the chimney extract is extracted at room temperature, cooled and filtered, then concentrated under reduced pressure and freeze-dried at 50 ° C or less.
또한, 본 발명은 상기 화장료 조성물이 화장수, 젤, 수용성 리퀴드, 크림, 연고, 에센스, 샴푸, 헤어린스, 헤어트리트먼트, 헤어무스, 립스틱, 수중유(O/W)형 및 유중수(W/O)형의 제형 중에서 선택되는 것을 특징으로 한다. In addition, the present invention is the cosmetic composition is a lotion, gel, water-soluble liquid, cream, ointment, essence, shampoo, hair rinse, hair treatment, hair mousse, lipstick, oil-in-water (O / W) type and water-in-oil (W / It is characterized by being selected from O) type formulations.
또한, 본 발명의 침피 추출물은 캡슐제, 액상제, 연고제, 첩부제 또는 약학적으로 허용되는 담체를 이용한 서방화 제제 등의 약학 조성물로 제제화할 수 있으며, 약리학적으로 허용되는 기제, 운반제, 부형제, 결합제(예: 전분, 트래거캔스 고무, 젤라틴, 당밀, 폴리비닐 알콜, 폴리비닐에테르, 폴리비닐 피롤리돈, 히드록시프로필 셀룰로오스, 메틸 셀룰로오스, 에틸 셀룰로오스 및 카르복시메틸 셀룰로오스), 분쇄제(예: 한천, 전분, 벨라틴 가루, 카르복시메틸 셀룰로오스 나트륨, 카르복시메틸 셀룰로오스 칼슘, 결정 셀룰로오스, 탄산칼슘, 탄산수소나트륨 및 알긴산 나트륨), 윤활제(예: 스테아린산 마그네슘, 활석, 수첨 식물유) 및 착색제 등을 포함한다. 상기 운반제 및 부형제로는 젖당, 글루코오스, 수크로오스, 만니톨, 감자녹말, 옥수수녹말, 탄산칼슘, 인산칼슘 및 셀룰로오스 등을 사용한다.In addition, the chimney extract of the present invention can be formulated into pharmaceutical compositions such as capsules, liquids, ointments, patch or sustained release preparations using a pharmaceutically acceptable carrier, pharmacologically acceptable bases, carriers, Excipients, binders (e.g. starch, tragacanth rubber, gelatin, molasses, polyvinyl alcohol, polyvinyl ether, polyvinyl pyrrolidone, hydroxypropyl cellulose, methyl cellulose, ethyl cellulose and carboxymethyl cellulose), crushing agents ( Examples: Agar, starch, bellatine powder, sodium carboxymethyl cellulose, calcium carboxymethyl cellulose, crystalline cellulose, calcium carbonate, sodium hydrogencarbonate and sodium alginate), lubricants (e.g. magnesium stearate, talc, hydrogenated vegetable oil) and coloring agents Includes. Lactose, glucose, sucrose, mannitol, potato starch, cornstarch, calcium carbonate, calcium phosphate and cellulose are used as the carrier and excipients.
상기 외에도 안정화제, 용해보조제, 경피흡수 촉진제 등의 보조제 방향제, 방부제 등의 첨가제가 더 첨가될 수 있다.In addition to the above, additives such as stabilizers, dissolution aids, adjuvant fragrances such as transdermal absorption accelerators, and preservatives may be further added.
이와 같이 제조되는 약학 조성물은 증상에 따라 일일 1회 내지 수회 피부에 적용할 수 있으며 증상의 호전 정도에 따라 적용을 조절할 수 있다.The pharmaceutical composition prepared as described above may be applied to the skin once or several times a day depending on the symptoms, and the application may be adjusted according to the degree of improvement of symptoms.
이하, 실시예를 통해 본 발명을 좀더 구체적으로 설명한다. 단, 이들 실시예는 본 발명의 예시적인 기재일 뿐이며, 본 발명의 범위가 이들 실시예에 국한되는 것은 아니다.Hereinafter, the present invention will be described in more detail through examples. However, these examples are merely illustrative of the present invention, and the scope of the present invention is not limited to these examples.
실시예 1: 침피 추출물 제조Example 1: Preparation of chimney extract
세절하여 음건한 물푸레나무의 줄기 껍질을 정제수에 70%(v/v) 에탄올 수용액으로 6시간 환류추출하고 냉각한 후, 와트만(Whatman) #5 여과지로 여과하였다. 여과된 추출물은 50℃ 이하에서 감압농축 및 동결건조하여 분말상의 추출물을 제조하였다.After slicing, the stem bark of the shaded ash tree was refluxed for 6 hours in 70% (v / v) ethanol aqueous solution in purified water, cooled, and then filtered with Whatman # 5 filter paper. The filtered extract was concentrated under reduced pressure and freeze-dried at 50 ° C or lower to prepare a powdery extract.
실시예 2: 침피 추출물의 5 알파-리덕타아제 활성 억제력 평가실험Example 2: Evaluation test of 5 alpha-reductase activity inhibitory activity of chimney extract
본 실시예는 상기 실시예 1에서 수득한 침피 추출물의 탈모방지 및 여드름방지효과를 판단하기 위해 5 알파-리덕타아제 활성 억제력을 평가하였다. 5 알파-리덕타아제 활성억제 실험에 사용된 5 알파-리덕타아제는 포피 유래의 섬유아세포가 생성하는 효소를 사용하였다.In this example, 5 alpha-reductase activity inhibitory powers were evaluated to determine the anti-hair loss and anti-acne effects of the chimpanzee extract obtained in Example 1. 5 Alpha-reductase activity inhibition The 5 alpha-reductase used in the experiment was an enzyme produced by fibroblast-derived fibroblasts.
섬유아세포를 마이크로플레이트 홀(microplate hole)마다 10,000개의 세포가 들어가도록 접종한 후 배양하였다. 각 홀마다 3H(트리튬)으로 방사선표지(radiolabelling)된 테스토스테론을 0.1.mμ.Ci 첨가한 후에 배양하여 섬유아세포가 이를 이용하는지 측정하였다. 침피 추출물이 들어가지 않은 것을 대조군으로 삼았다. 24시간 배양 후 상등액을 얻고 에틸아세테이트(ethyl acetate)-사이클로헥산(cyclohexane) 1:1 추출용매 1㎖로 스테로이드(steroids)를 얻는다. 얻어진 스테로이드를 박막크로마토그래피 판에 올려놓고 클로로포름/메탄올 혼합액98/2(v/v)로 전개시킨다. 테스토스테론과 디하이드로테스토스테론에 해당하는 점의 방사활성을 덴시토미터를 이용하여 측정하여 전환율을 계산하고, 그 결과를 대조군(추출물을 첨가하지 않았을 때의 전환율)과 비교하여 하기 수학식 1에 의해 5 알파-리덕타아제 저해능을 평가하였다.Fibroblasts were cultured after inoculation with 10,000 cells per microplate hole. After adding 0.1.mμ.Ci of testosterone radiolabeled with 3H (tritium) for each hole, it was cultured to measure whether fibroblasts use it. As a control, what did not contain the chimpanzee extract was used. After incubation for 24 hours, a supernatant is obtained, and steroids are obtained with 1 ml of ethyl acetate-cyclohexane 1: 1 extraction solvent. The obtained steroid is placed on a thin-film chromatography plate and developed with a mixture of chloroform / methanol 98/2 (v / v). The radioactivity at the points corresponding to testosterone and dihydrotestosterone was measured using a densitometer to calculate the conversion rate, and the result was compared with the control group (conversion rate when no extract was added) by Equation 1 below. The ability to inhibit alpha-reductase was evaluated.
<수학식 1><Equation 1>
저해능(%)=(A-B)/A ×100Inhibitory capacity (%) = (A-B) / A × 100
[ A=테스토스테론에서 다이하이드로테스토스테론으로의 전환율(추출물 미첨가시)][A = Testosterone to dihydrotestosterone conversion rate (without extract)]
[ B=테스토스테론에서 다이하이드로테스토스테론으로의 전환율(추출물 첨가시)][B = Conversion rate from testosterone to dihydrotestosterone (when extract is added)]
상기 수학식에 따른 계산 결과, 아래 표 1과 같이 침피 추출물은 5알파-리덕타아제 저해효과가 있음을 알 수 있다.As a result of the calculation according to the above equation, it can be seen that the chimney extract has a 5 alpha-reductase inhibitory effect as shown in Table 1 below.
실시예 3: 모발 성장 효과 시험Example 3: Hair growth effect test
본 실시예는 실시예 1에서 침피 추출물 건조 엑기스 2% 를 함유하는 30% 함수 에탄올(ethanol) 용액을 제조하여 시험에 사용하였다. 모발성장 효과 시험은 마우스(ICR) 생후 47~53 일 것을 사용하여 등 부위 털을 제거하고, 등 부위가 깨끗한 것을 골라 물질군마다 10마리를 사용하여 다음날부터 매일 실시예의 시험물질을 개체당 100㎖씩 도포하였다. 시간 경과에 따른 모발의 길이 및 모발 성장 정도를 모 제거 후 복원 정도에 따라 점수를 부가하여 각각 비교하였다. 모발 성장 정도를 비교하기 위하여, 대조군으로는 30% 알코올 용액을 각 개체에 도포하여 성장 상태를 관찰하였다.In this example, a 30% hydrous ethanol solution containing 2% dry extract of chimney extract in Example 1 was prepared and used in the test. For the hair growth effect test, the hair of the back was removed using a mouse (ICR) 47-53 days old, the clean back was selected, and 10 animals were used for each substance group. Each was applied. The length of the hair and the degree of hair growth over time were compared by adding scores according to the degree of restoration after hair removal. In order to compare the degree of hair growth, as a control, a growth state was observed by applying a 30% alcohol solution to each individual.
실시예 4: 여드름균에 대한 항균력 측정Example 4: Measurement of antibacterial activity against acne bacteria
본 실시예는 실시예 1에서 수득한 침피 추출물의 여드름균에 대한 항균력을 확인하기 위한 페이퍼 디스크 테스트(Paper Disc Test)를 실시하였다. 먼저, 여드름 발생 원인인 피부 상재균 프로피오니박테리움 아크네(Propionibacterium acnes)를 활성화시키기 위하여 BHI 액체배지(Brain-Heart Infusion Broth;3.7%)에서 48시간 전배양하였다. 이렇게 준비한 균 배양액을 BHI 고체배지(Brain-Heart Infusion Broth;3.7%;agar1.5%)에 0.1㎖씩 도말한 후, 건조하였다. 실시예 1에서 수득한 침피 추출물을 각각 95% 에탄올 수용액에 12%(w/v)로 희석하여 직경 8㎜의 페이퍼 디스크에 50㎕씩 점적한 후 앞서 준비한 고체배지 위에 올려놓은 후 이것을 35㎕ 혐기 배양조에서 3일간 배양하였다. 페이퍼 디스크 주변에 생긴 균 성장 저지 영역을 관찰하고 저지환의 크기를 측정함으로써 항균력을 평가하였다.This example was carried out a paper disc test (Paper Disc Test) for confirming the antibacterial activity of acne bacteria of the chimpanzee extract obtained in Example 1. First, pre-incubation was performed in BHI liquid medium (Brain-Heart Infusion Broth; 3.7%) for 48 hours in order to activate Propionibacterium acnes, which is the cause of acne. The prepared bacterial culture solution was applied to BHI solid medium (Brain-Heart Infusion Broth; 3.7%; agar 1.5%) 0.1 ml each, and then dried. After diluting the chimney extract obtained in Example 1 with 12% (w / v) in 95% ethanol aqueous solution, dropping 50 µl each onto a paper disc having a diameter of 8 mm and placing it on the prepared solid medium, and then 35 µl anaerobic it Incubated in the culture tank for 3 days. Antibacterial activity was evaluated by observing the area of growth inhibition around the paper disc and measuring the size of the ring.
여드름균에 대한 항균력을 측정한 결과, 침피 추출물의 균 성장 저지환의 크기는 24 ㎜인 것으로 나타났다.As a result of measuring the antibacterial activity against acne bacteria, it was found that the size of the growth inhibition ring of the chimney extract was 24 mm.
실시예 5: 피지 분비 억제 및 여드름 개선 효과Example 5: Sebum secretion suppression and acne improvement effect
본 실시예는 실시예 1에서 수득한 침피 추출물을 함유한 화장료를 제조하여 사람을 대상으로 피지 분비 억제 효과 및 여드름 개선 효과를 비교예 1과 비교실험을 행하여 평가하였다.In this example, the cosmetic composition containing the chimney extract obtained in Example 1 was prepared, and the effect of inhibiting sebum secretion and acne improvement was evaluated by performing comparative experiments with Comparative Example 1.
비교실험에 사용된 화장료는 크림형태이고, 그 조성은 표 3에 나타낸 바와 같다. 우선 표 3에 기록되어 있는 나)상을 가열하여 70℃에 보존한다. 이것에 가)상을 가하여 예비유화 후 호모믹서로 균일하게 유화하고 다음에 서서히 냉각하여 크림(실시예 5, 비교예 1)을 제조한다. 실험자(20세-35세의 남녀) 10명을 대상으로 A, B 두 그룹으로 나누어 실험을 실시하였다. A 그룹에는 침피 추출물이 함유된 실시예 5에서 제조된 크림을, B 그룹에는 비교예 1에서 제조된 크림을 매일 아침, 저녁 세안 후 4주간 사용하도록 하였다.The cosmetic used in the comparative experiment is in the form of a cream, and the composition is shown in Table 3. First, the phase B) recorded in Table 3 is heated and stored at 70 ° C. To this, a) phase was added, followed by pre-emulsification, uniformly emulsified with a homomixer, and then slowly cooled to prepare a cream (Example 5, Comparative Example 1). The experiment was conducted by dividing into two groups A and B for 10 experimenters (men and women aged 20-35). In Group A, the cream prepared in Example 5 containing the chimney extract, and in Group B, the cream prepared in Comparative Example 1 was used every morning and evening for 4 weeks after cleansing.
피지 측정은 세안 후 30분간 항온, 항습실에서 피를 안정시킨 후 피지측정기(Sebumeter)를 이용하여, 이마에서 피지량을 측정하였다. 침피 추출물을 함유하는 크림(실시예 5)을 사용하기 전 피지량을 초기값으로 설정하였으며, 매주 1회 4주간 피지량의 변화를 측정하였다. 표 4에서 나타난 바와 같이 침피 추출물을 함유한 크림을 도포한 실험자가 시간이 지남에 따라 피지 분비를 효과적으로 감소시킴을 알 수 있다.For sebum measurement, the blood was stabilized in a constant temperature and humidity chamber for 30 minutes after washing, and sebum was measured in the forehead using a sebum meter. Before using the cream containing the chimney extract (Example 5), the sebum amount was set as the initial value, and the change in sebum amount was measured once every week for 4 weeks. As shown in Table 4, it can be seen that the experimenter who applied the cream containing the chimney extract effectively reduced sebum secretion over time.
가)알콜에스테르Polyoxyethylene (25 mol parts
A) Alcohol ester
아스테르Glyceryl monostearic acid
Aster
주)단위: 중량%Note) Unit:% by weight
여드름이 발생한 실험자(20세-35세의 남녀) 10명을 대상으로 실시예 5에 제조된 크림을 아침, 저녁으로 4주간 얼굴 전체에 고루 도포하게 하였다. 여드름 개선 효과의 판정은 실험자 본인이 느끼는 정동에 따라 판정 기준을 1-3점으로 시험전 상태를 평가한 뒤 여드름 치유 효과를 평가하도록 하였으며, 그 결과를 표 5에 나타내었다.The cream prepared in Example 5 was applied to the entire face for 4 weeks in the morning and evening in 10 subjects who had acne (20-35 years old male and female). The acne improvement effect was evaluated by evaluating the condition before the test with 1-3 points based on the emotions of the experimenter himself, and the results are shown in Table 5.
1 = 여드름 조금 있음 2 = 여드름 약간 있음 3 = 여드름 심함
<여드름 효과 판정>
- : 효과 거의 없음 + : 약간의 효과 있음 ++ : 많이 완화
+++ : 완전히 치유됨<Evaluation of state before test>
1 = some acne 2 = some acne 3 = severe acne
<Acne effect judgment>
-: Almost no effect +: little effect ++: much relief
+++: Healed completely
상기의 표 5의 결과로부터, 본 발명의 침피 추출물을 함유한 크림을 사용한 시험자들에서 여드름 개선 효과를 확인할 수 있었다.From the results of Table 5 above, it was possible to confirm the acne improvement effect in the testers using the cream containing the chimney extract of the present invention.
실시예 6: 피부자극 완화 효과Example 6: Skin irritation relief effect
본 실험예에서는 실시예 1에서 수득한 침피 추출물을 함유한 화장료의 자극 완화 효과를 인체 첩포 실험으로 평가하였다.In this experimental example, the effect of alleviating irritation of a cosmetic containing the chimney extract obtained in Example 1 was evaluated by a human patch test.
일반적 화장품 처방(크림, 로션, 스킨, 에센스)에 자극을 일으키는 SLS(sodium lauryl sulfate) 1%와 실시예 5에서 제조된 제품을 혼용하여 24시간, 48시간, 72시간 동안 첩포하여 자극 유발지수를 바탕으로 자극완화 효과를 평가한 것이다.1% of sodium lauryl sulfate (SLS) that causes irritation to the general cosmetic prescription (cream, lotion, skin, essence) and the product prepared in Example 5 are mixed and patched for 24 hours, 48 hours, and 72 hours to obtain an irritation-inducing index. Based on this, the effect of stimulation is evaluated.
20-50세의 건강한 남녀 50명의 팔 상박 부위에 FINN CHAMBER(FINLAND)를 이용하여 각각의 제품을 0.3mg 씩 첩포하고, 24시간 후 급성 자극 지수를 평가하였다. 평가 후 재차 동일한 부위에 동량의 제품을 첩포하고 48시간 및 72시간 후의 지연성 자극 지수를 평가하였다.Each of the 50-50 healthy males and females aged 20-50 years old was patched with 0.3 mg of each product using FINN CHAMBER (FINLAND), and the acute irritation index was evaluated after 24 hours. After evaluation, the same amount of product was applied to the same site again, and the delayed irritation index after 48 hours and 72 hours was evaluated.
시험 결과 SLS를 단독으로 첩포한 부분은 24시간 후부터 피부에 붉게 자극이 나타났으나, 침피 추출물을 함유하는 제품을 첩포하고 24시간, 48시간, 72시간 경과 후에도 아무런 피부 발작을 일으키지 않았다.As a result of the test, the part where the SLS was applied alone showed a red irritation on the skin after 24 hours, but it did not cause any skin seizure even after 24 hours, 48 hours, and 72 hours elapsed after application of the product containing the chimney extract.
이 평가의 결과는 침피 추출물이 화장료에 혼용되었을 때 자극을 유발시키는 기재(계면 활성제, 향, 알콜)에 의한 피부 자극을 감소시킬 수 있는 유의한 효과가 있음을 나타내었다.The results of this evaluation showed that the chimpanzee extract has a significant effect in reducing skin irritation caused by substrates (surfactants, fragrances, alcohols) that cause irritation when used in cosmetics.
이하에 그 외의 실시예를 나타내었다. 즉, 실시예 1에서 수득한 침피 추출물을 함유한 샴푸, 화장수, 유액 및 미용액을 실시예 7 내지 10에서 제조하였다. 이들 침피 추출물을 함유한 샴푸, 화장수, 유액 및 미용액은 과다 피지 분비 억제효과, 여드름 방지효과, 모발손상 방지효과, 탈모방지 및 육모 효과 등 피부개선에 우수한 효과를 나타내었다.Other examples are shown below. That is, the shampoo, lotion, emulsion and cosmetic liquid containing the chimpanzee extract obtained in Example 1 were prepared in Examples 7 to 10. Shampoos, lotions, emulsions and cosmetic liquids containing these chimney extracts showed excellent effects in skin improvement such as excessive sebum secretion suppression effect, acne prevention effect, hair damage prevention effect, hair loss prevention and hair growth effect.
실시예 7: 침피 추출물을 함유한 샴푸 제조Example 7: Preparation of shampoo containing chimney extract
95% 에탄올 5g에 암모늄라우레스설페이트 5g, 코실베타인 5g, 알킬에테르셀페이트 0.5g, 실리콘 0.5g, 폴리쿼터 0.2g, 향료 0.2g, 보존제 0.02g를 혼합하였다. 실시예 1에서 수득한 본 발명의 침피 추출물 5g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 샴푸를 얻었다.5 g of 95% ethanol was mixed with 5 g of ammonium laureth sulfate, 5 g of cosylbetaine, 0.5 g of alkyl ether sulfate, 0.5 g of silicone, 0.2 g of polyquarter, 0.2 g of fragrance, and 0.02 g of preservative. 5 g of the chimney extract of the present invention obtained in Example 1 and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixture was added and stirred to obtain a shampoo.
실시예 8: 침피 추출물을 함유한 화장수 제조Example 8: Preparation of lotion containing chimney extract
95% 에탄올 8g에 폴리피로리돈 0.05g, 올레일알콜 0.1g, 폴리옥시에틸렌모노올레이트 0.2g, 향료 0.2g, 파라옥시안식향산메틸에스테르 0.1g, 소량의 산화방지제, 소량의 색소를 혼합용해 한다. 실시예 1에서 수득한 침피 추출물 0.05g, 글리세린 5g을 정제수 85.33g에 용해한 것에 상기 혼합액을 첨가한 후 교반하여 화장수를 얻었다.To 8 g of 95% ethanol, 0.05 g of polypyrrolidone, 0.1 g of oleyl alcohol, 0.2 g of polyoxyethylene monooleate, 0.2 g of fragrance, 0.1 g of paraoxybenzoic acid methyl ester, a small amount of antioxidant, and a small amount of pigment are mixed and dissolved. . 0.05 g of the chimney extract obtained in Example 1 and 5 g of glycerin were dissolved in 85.33 g of purified water, and the mixture was added and stirred to obtain a lotion.
실시예 9: 침피 추출물을 함유한 유액 제조Example 9: Preparation of emulsion containing chimney extract
세틸알콜 1.2g, 스쿠알란 10g, 바세린 2g, 파라옥시안식향산에틸에스테르 0.2g, 글리세린모노에스테아레이드 1g, 폴리옥시에틸렌(20몰 부가)모노올레이트 1g및 향료 0.1g을 70℃에서 가열혼합용해하고, 실시예 1에서 수득한 침피 추출물 0.5g, 디프로필렌글리콜 5g, 폴리에틸렌글리콜-1500 2g, 트리에탄올아민 0.2g, 정제수 76.2g을 75℃로 가열해서 용해시킨다. 양자를 혼합하여 유화시킨 후 냉각하여 수중유(O/W)형의 유액을 얻었다.1.2 g of cetyl alcohol, 10 g of squalane, 2 g of vaseline, 0.2 g of paraoxybenzoic acid ethyl ester, 1 g of glycerin monoesterade, 1 g of polyoxyethylene (addition of 20 mol) monooleate, and 0.1 g of fragrance were heated and dissolved at 70 ° C. , 0.5 g of chimney extract obtained in Example 1, 5 g of dipropylene glycol, 2 g of polyethylene glycol-1500, 0.2 g of triethanolamine, and 76.2 g of purified water were dissolved by heating to 75 ° C. The mixture was emulsified by mixing and cooled to obtain an oil-in-water (O / W) emulsion.
실시예 10: 침피 추출물을 함유한 미용액 제조Example 10: Preparation of cosmetic liquid containing chimney extract
95% 에틸알콜 5g에 폴리옥시에틸렌솔비탄모노올레이트 1.2g, 키툴로오즈 0.3g, 히아루론산나트륨 0.2g, 비타민 E-아세테이트 0.2g, 감초산 나트륨 0.2g, 파라옥시안식향산에틸에스테르 0.1g, 실시예 1에서 수득한 침피 추출물 1g 및 적량의 색소를 혼합하여 미용액을 얻었다.Polyoxyethylene sorbitan monooleate 1.2g, chitulose 0.3g, sodium hyaluronate 0.2g, vitamin E-acetate 0.2g, sodium licorice 0.2g, paraoxybenzoic acid ethyl ester 0.1g, 5g 95% ethyl alcohol 1 g of the chimney extract obtained in Example 1 and an appropriate amount of pigment were mixed to obtain a cosmetic liquid.
실시예 11: 침피 추출물을 함유한 화장수 제조 2Example 11: Preparation of lotion containing chimney extract 2
실시예 8과 같이 제조하되, 묘수초 발효액을 더 첨가하여 제조하였다.Prepared as in Example 8, was prepared by further adding the myochoweed fermentation broth.
묘수초는 학명이 Orthosiphon stamineus Bentham이고, 일반적으로는 "Cat Whiskers"로 불리는 꿀풀과로 우리나라 말로는 고양이 수염풀이라고도 한다.Myocho is a scientific name of Orthosiphon stamineus Bentham, and is generally called "Cat Whiskers". It is also called cat whiskers in Korean.
주로 자라는 지역이 인도네시아이며, 민간에서는 차로 마시기도 한다.The region where it grows mainly is Indonesia.
한편, 아직까지 묘수초를 모발 관련 화장수의 원료로 사용한 사례는 보고되어 있지 않은 상태이다.On the other hand, there have been no reports of using myocho as a raw material for hair-related lotion.
묘수초 발효액은 묘수초 잎을 수득한 다음, 묘수초, 소금, 식초를 1 : 3 : 1의 비율로 혼합한 다음 1개월동안 발효시키고, 고형물을 분리한 상등액만을 수득한 것을 사용하였다.The myochoweed fermentation broth was used to obtain a myochoweed leaf, then mix myochoweed, salt, and vinegar in a ratio of 1: 3: 1, then ferment for 1 month, and obtain only the supernatant from which solids were separated.
95% 에탄올 8g에 폴리피로리돈 0.05g, 올레일알콜 0.1g, 폴리옥시에틸렌모노올레이트 0.2g, 향료 0.2g, 파라옥시안식향산메틸에스테르 0.1g, 소량의 산화방지제, 소량의 색소를 혼합용해 한다. 실시예 1에서 수득한 침피 추출물 0.05g, 글리세린 5g을 정제수 84.33g에 용해하고, 묘수초 발효액을 1g 첨가하여 혼합한 것에 상기 혼합액을 첨가한 후 교반하여 화장수를 얻었다.To 8 g of 95% ethanol, 0.05 g of polypyrrolidone, 0.1 g of oleyl alcohol, 0.2 g of polyoxyethylene monooleate, 0.2 g of fragrance, 0.1 g of paraoxybenzoic acid methyl ester, a small amount of antioxidant, and a small amount of pigment are mixed and dissolved. . 0.05 g of the chimpanzee extract obtained in Example 1 and 5 g of glycerin were dissolved in 84.33 g of purified water, and 1 g of the myochoweed fermentation broth was added to the mixture, followed by stirring to obtain a lotion.
제조된 화장수에 모발을 20분 동안 담근 후 모발의 인장강도를 측정하였다.After soaking the hair in the prepared lotion for 20 minutes, the tensile strength of the hair was measured.
이때, 모발의 인장 강도 측정은 디지털 포스 게이지(DPS-5R)를 사용하였으며, 측정은 10회 실시하였다.In this case, a digital force gauge (DPS-5R) was used to measure the tensile strength of the hair, and the measurement was performed 10 times.
비교 대상으로는 실시예 8의 화장수와, 순수한 모발에 20분 동안 침지시킨 상태에서 비교하였다.For comparison, the lotion of Example 8 was compared with pure hair immersed for 20 minutes.
측정 결과 실시예 11의 화장수에 침지된 모발 인장강도는 수치가 0.114kg으로 측정된 반면, 순수한 물에 담궈뒀던 모발 인장강도는 0.091kg으로 측정되었다.As a result of the measurement, the tensile strength of the hair immersed in the lotion of Example 11 was measured to be 0.114 kg, while the tensile strength of the hair dipped in pure water was measured to be 0.091 kg.
참고로, 실시예 8의 경우 모발 인장강도 수치가 0.106kg으로 측정되었다.For reference, in Example 8, the tensile strength of the hair was measured to be 0.106 kg.
따라서, 본 발명의 침피 추출물이 모발 인장강도를 향상시키는 효과가 있음을 알 수 있고, 여기에 묘수초 발효액을 첨가하였을 경우 그 효과가 보다 증가함을 알 수 있었다.Therefore, it can be seen that the chimpanzee extract of the present invention has an effect of improving the tensile strength of hair, and when the fermentation broth of the myelin sheath is added thereto, the effect is further increased.
Claims (10)
글리세린 및 침피 추출물이 용해된 정제수와, 에탄올 및 묘수초 발효액을 포함하여 구성되되,
상기 정제수 100 중량부를 기준으로 에탄올은 9.4 ~ 9.5 중량부로 구성되고,
상기 침피 추출물은 정제수 100 중량부를 기준으로 0.057 ~ 0.059 중량부로 구성되며,
상기 묘수초 발효액은 정제수 100 중량부를 기준으로 1.18 ~ 1.19 중량부로 구성되고,
상기 침피 추출물은, 세절하여 음건한 물푸레나무의 줄기 껍질을 정제수에 70%(v/v) 에탄올 수용액으로 6시간 환류추출하고 냉각한 후, 여과지로 여과한 다음, 여과된 추출물은 50℃ 이하에서 감압농축 및 동결건조하여 제조되고,
상기 묘수초 발효액은, 묘수초 잎을 수득한 다음, 묘수초, 소금, 식초를 1 : 3 : 1의 비율로 혼합한 다음 1개월동안 발효시키고, 고형물을 분리한 상등액만을 수득하여 제조되는 것을 특징으로 하는,
침피 추출물을 이용한 화장료 조성물.In the cosmetic composition,
Consists of purified water in which glycerin and chimney extract are dissolved, and ethanol and seedling plant fermentation broth.
Ethanol is composed of 9.4 to 9.5 parts by weight based on 100 parts by weight of the purified water,
The chimney extract is composed of 0.057 to 0.059 parts by weight based on 100 parts by weight of purified water,
The myochoweed fermentation broth is composed of 1.18 to 1.19 parts by weight based on 100 parts by weight of purified water,
The chimney extract is excised, refluxed the stem bark of a shaded ash tree into purified water with 70% (v / v) ethanol aqueous solution for 6 hours, cooled, filtered with filter paper, and the filtered extract was below 50 ° C. It is prepared by concentration under reduced pressure and lyophilization,
The myochoweed fermentation broth is prepared by obtaining a myochoweed leaf, mixing myochoweed, salt, and vinegar in a ratio of 1: 3 and then fermenting for 1 month, and obtaining only the supernatant from which the solids are separated. Made with,
Cosmetic composition using chimney extract.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190062728A KR102093708B1 (en) | 2019-05-28 | 2019-05-28 | A cosmetic composition using Fraxini cortex extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020190062728A KR102093708B1 (en) | 2019-05-28 | 2019-05-28 | A cosmetic composition using Fraxini cortex extract |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102093708B1 true KR102093708B1 (en) | 2020-03-27 |
Family
ID=69959345
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020190062728A Active KR102093708B1 (en) | 2019-05-28 | 2019-05-28 | A cosmetic composition using Fraxini cortex extract |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102093708B1 (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070022936A (en) * | 2005-08-22 | 2007-02-28 | 한불화장품주식회사 | External skin composition containing dermis extract as main active ingredient |
KR20110006388A (en) * | 2009-07-14 | 2011-01-20 | 한국 한의학 연구원 | Composition for the prevention and treatment of irritable skin disease containing dermis extract as an active ingredient |
KR20120086262A (en) * | 2011-01-25 | 2012-08-02 | 한국폴리텍특성화대학 산학협력단 | Fraxinus rhynchophylla Hance extracts compositions for treating or preventing inflammatory diseases |
KR101269490B1 (en) * | 2012-07-09 | 2013-05-30 | 연세대학교 산학협력단 | Composition for preventing or treating hair loss or stimulating hair sprouting comprising secoiridoid glucoside derivatives as active ingredients |
KR20140032537A (en) * | 2012-08-30 | 2014-03-17 | 이영조 | For relieve itching scalp and glittery hair elastic to no rinse shampoo composition |
KR20160136705A (en) * | 2015-05-20 | 2016-11-30 | 한국과학기술연구원 | Composition for anti-allergy and skin hydration comprising fraxinus rhynchophylla extracts |
KR101807577B1 (en) * | 2016-06-10 | 2017-12-11 | 주식회사 에코케이션 | Traditional oriental medicine shampoo composition and manufacturing method thereof) |
-
2019
- 2019-05-28 KR KR1020190062728A patent/KR102093708B1/en active Active
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070022936A (en) * | 2005-08-22 | 2007-02-28 | 한불화장품주식회사 | External skin composition containing dermis extract as main active ingredient |
KR100732564B1 (en) | 2005-08-22 | 2007-06-27 | 한불화장품주식회사 | External skin composition containing dermis extract as main active ingredient |
KR20110006388A (en) * | 2009-07-14 | 2011-01-20 | 한국 한의학 연구원 | Composition for the prevention and treatment of irritable skin disease containing dermis extract as an active ingredient |
KR20120086262A (en) * | 2011-01-25 | 2012-08-02 | 한국폴리텍특성화대학 산학협력단 | Fraxinus rhynchophylla Hance extracts compositions for treating or preventing inflammatory diseases |
KR101269490B1 (en) * | 2012-07-09 | 2013-05-30 | 연세대학교 산학협력단 | Composition for preventing or treating hair loss or stimulating hair sprouting comprising secoiridoid glucoside derivatives as active ingredients |
KR20140032537A (en) * | 2012-08-30 | 2014-03-17 | 이영조 | For relieve itching scalp and glittery hair elastic to no rinse shampoo composition |
KR20160136705A (en) * | 2015-05-20 | 2016-11-30 | 한국과학기술연구원 | Composition for anti-allergy and skin hydration comprising fraxinus rhynchophylla extracts |
KR101807577B1 (en) * | 2016-06-10 | 2017-12-11 | 주식회사 에코케이션 | Traditional oriental medicine shampoo composition and manufacturing method thereof) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013027984A2 (en) | Cosmetic composition containing green tea component | |
US7189419B2 (en) | Use of active extracts to lighten skin, lips, hair, and/or nails | |
KR20150007975A (en) | Composition for promoting hair growth and restoration | |
KR20140126892A (en) | External composition for skin containing Ginsenoside Rg3 | |
KR101458496B1 (en) | A skin-care agent for anti-inflammatory containig Pleurotus ferulae fruit body extract or Pleurotus ferulae mycelium extract or Pleurotus ferulae mycelium culture fluid | |
KR101402193B1 (en) | Cosmetic composition for skin whitening containig pleurotus ferulae fruit body extract or pleurotus ferulae mycelium extract or pleurotus ferulae mycelium culture fluid | |
KR101359278B1 (en) | Composition comprising the extract of seaweeds for prevention of losing hair or promotion of growing hair | |
KR100482694B1 (en) | Liposome base for trichogenousness, Cosmetic composition for trichogenousness containing the same, and Method for improving absorptance of natural ingredients for trichogenousness using the same | |
JPH04338313A (en) | Cosmetic | |
JPH0812560A (en) | Skin external preparation | |
KR101252550B1 (en) | Cosmetic composition for protecting sebum secretion on the skin | |
KR101484685B1 (en) | Composition comprising Angelica keiskei extract as active ingredient | |
KR100829729B1 (en) | Skin external preparation composition containing extracts of medicinal herbs as main active ingredients | |
ITRM20130657A1 (en) | TREATMENT OF DERMATOPATHIES BY VEGETAL EXTRACT BY DAPHNE LAUREOLA | |
JP6267957B2 (en) | Sebum synthesis inhibitor | |
KR20000022127A (en) | Scalp care compositions | |
KR102093708B1 (en) | A cosmetic composition using Fraxini cortex extract | |
KR20090126992A (en) | Camellia gourd (camellia seed shell powder) and its use | |
JP5000964B2 (en) | Testosterone 5α-reductase activity inhibitor, androgen receptor antagonist, use thereof, and method for suppressing androgen activity expression | |
KR20140126891A (en) | External composition for skin containing Ginsenoside Rf | |
KR20140081137A (en) | A skin-care agent containig Morchella esculenta fruit body extract or Morchella esculenta mycelium extract | |
KR100593511B1 (en) | Anti acne cosmetics using natural products | |
KR100702329B1 (en) | 5α-reductase activity inhibiting composition and sebum secretion inhibiting cosmetic composition containing Baekgulchae extract as an active ingredient | |
JP2002179584A (en) | TESTOSTERONE 5alpha-REDUCTASE INHIBITOR AND ANDROGEN RECEPTOR BINDING INHIBITOR, HAIR AGENT AND SKIN COSMETIC | |
JP2021001126A (en) | Agent for accelerating decomposition of melanosome in keratinocyte |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20190528 |
|
PA0201 | Request for examination | ||
PA0302 | Request for accelerated examination |
Patent event date: 20190528 Patent event code: PA03022R01D Comment text: Request for Accelerated Examination |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20190917 Patent event code: PE09021S01D |
|
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20191226 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20200213 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20200320 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20200323 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
PR1001 | Payment of annual fee |
Payment date: 20240131 Start annual number: 5 End annual number: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20250120 Start annual number: 6 End annual number: 6 |